Fox Christine Ann 4
4 · Mereo BioPharma Group plc · Filed Sep 13, 2024
Insider Transaction Report
Form 4
Fox Christine Ann
Chief Financial Officer
Transactions
- Exercise/Conversion
Performance Based Restricted Stock Unit
2024-09-11−60,000→ 0 totalExercise: $0.00From: 2024-09-11Exp: 2025-01-25→ American Depository Shares (60,000 underlying) - Exercise/Conversion
American Depositary Shares representing Ordinary Shares
2024-09-11+60,000→ 117,571 total
Footnotes (2)
- [F1]Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
- [F2]Represents performance-based restricted stock unit earned under the issuer's 2019 Employee Incentive Plan (the "Plan"), that vested on September 11, 2024 based on satisfaction of ADS price threshold values over a two year performance period.